Natasha Leighl
机构: Medical Oncology, Princess Margaret
每年引用次数
引用次数
引用: 47,794
H-指数: 90
I10-指数 : 359
出版物: 1,065
A systematic review of factors influencing older adults' decision to accept or decline cancer treatment.
Martine T.E. Puts , Brianne Tapscott , Margaret Fitch , Doris Howell
Cancer Treatment Reviews 41 ( 2) 197 -215
222
2015
Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.
Melania Pintilie , Fiona H. Blackhall , Frances A. Shepherd , Ronald Feld
Clinical Cancer Research 9 ( 6) 2241 -2247
96
2003
Prognostic impact of patterns of nodal subcategories and pleural or pericardial effusions in Small Cell Lung Cancer (SCLC)
Demetris Patsios , Natasha Leighl , Clement Ma , Zarnie Lwin
Journal of Thoracic Oncology 4 ( 9)
2009
New perspectives for the future treatment option in NSCLC
Natasha Leighl
대한결핵및호흡기학회 추계학술발표초록집 127 16 -16
2019
Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.
Marc de Perrot , Penelope A Bradbury , Kasia Czarnecka , Kasia Czarnecka
Lancet Oncology 22 ( 2) 190 -197
1
2021
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials.
Joseph Pater , Natasha Leighl , Kelvin Kw Chan , Kelvin Kw Chan
Clinical Trials 17407745211005045 -17407745211005045
2021
Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities.
Yada Kanjanapan , Daphne Day , Lisa Wang , Hamad Al‐Sawaihey
Cancer 125 ( 8) 1341 -1349
124
2019
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.
Aaron R. Hansen , Kari Ala‐Leppilampi , Chris McKillop , Lillian L. Siu
Cancer 126 ( 7) 1550 -1558
21
2020
Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma
Paul Wheatley-Price , Boming Yang , Demetris Patsios , Devalben Patel
Journal of Clinical Oncology 28 ( 20) 3316 -3322
77
2010
Evan's Syndrome Associated with Pembrolizumab Therapy in Metastatic Non-Small Cell Lung Cancer
Anthony Lott , Marcus Butler , Natasha Leighl , Christine M. Cserti-Gazdewich
Blood 126 ( 23) 4543 -4543
5
2015
Determinants of quality of life in patients with advanced cancer
Camilla Zimmermann , Debika Burman , Nadia Swami , Monika K. Krzyzanowska
Supportive Care in Cancer 19 ( 5) 621 -629
66
2011
Enhancing decision making about participation in cancer clinical trials: development of a question prompt list
Richard F. Brown , Elyse Shuk , Natasha Leighl , Phyllis Butow
Supportive Care in Cancer 19 ( 8) 1227 -1238
33
2011
Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL)
Patricia J. Hollen , Richard J. Gralla , John A. Stewart , Jacinta M. Meharchand
Supportive Care in Cancer 21 ( 1) 165 -172
27
2013
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment
Deborah A Marshall , Ken Deal , Yvonne Bombard , Natasha Leighl
BMJ Open 6 ( 6) e010981
19
2016
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib.
Sabine Schmid , Erin L Stewart , Sebastiao N Martins-Filho , Michael Cabanero
Clinical Lung Cancer 21 ( 5)
1
2020
Abstract CT105: MK-3475 (anti-PD-1 monoclonal antibody) for non-small cell lung cancer (NSCLC): Antitumor activity and association with tumor PD-L1 expression
Leena Gandhi , Ani Balmanoukian , Rina Hui , Omid Hamid
Cancer Research 74
43
2014
Cost-Effectiveness Analysis Comparing Conventional Versus Stereotactic Body Radiotherapy for Surgically Ineligible Stage I Non–Small-Cell Lung Cancer
Gunita Mitera , Anand Swaminath , David Rudoler , Colleen Seereeram
Journal of Oncology Practice 10 ( 3)
21
2014
Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
Stefan Fischer , Gail Darling , Andrew F. Pierre , Alexander Sun
European Journal of Cardio-Thoracic Surgery 33 ( 6) 1129 -1134
37
2008
Chemotherapy and radiation treatment decision-making experiences of older adults with cancer: A qualitative study
Schroder Sattar , Shabbir M.H. Alibhai , Margaret Fitch , Monika Krzyzanowska
Journal of Geriatric Oncology 9 ( 1) 47 -52
13
2018
Protein-altering germline mutations implicate novel genes related to lung cancer development.
Xuemei Ji , Semanti Mukherjee , Maria Teresa Landi , Yohan Bosse
Nature Communications 11 ( 1) 2220
5
2020